Evofem Biosciences (EVFM) Misses Q3 EPS by 1c Nov 13, 2025 06:23PM
Evofem shareholders reject merger with Aditxt Oct 20, 2025 04:24PM
Evofem expects merger approval at Sept. 26 stockholder meeting Sep 9, 2025 09:28AM
Evofem Biosciences (EVFM) Misses Q2 EPS by 2c Aug 14, 2025 04:42PM
Evofem Biosciences (EVFM) Reports In-Line Q1 EPS May 15, 2025 04:51PM


Mar 24, 2025 04:17PM Evofem Biosciences (EVFM) Misses Q4 EPS by 3c
Mar 20, 2025 08:02AM Windtree Therapeutics, Inc. (WINT) Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
Nov 14, 2024 05:46PM Evofem Biosciences (EVFM) Misses Q3 EPS by 2c
Nov 8, 2024 08:35AM Aditxt, Inc (ADTX) Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Sep 24, 2024 08:15AM Evofem Biosciences (EVFM) Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt (ADTX)
Aug 20, 2024 08:17AM Evofem Biosciences (EVFM) Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
Jul 17, 2024 06:31AM Aditxt, Inc (ADTX) and Evofem (EVFM) Amend and Restate Merger Agreement, now Target September 30 Closing
Jun 11, 2024 08:36AM Evofem Biosciences (EVFM) Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter